# Feops NV

- Location (FDA's records): Gent-Zwijnaarde, BE
- FDA decisions: 4 (2021–2025): 3 510(k) clearances and 1 De Novo grant
- Product codes: QQI (3), QIH (1)
- Predicates its devices cite: 3 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Pie Medical Imaging BV: 1 (https://510kreport.com/company/pie-medical-imaging)

## Firms that cite its devices most
- Dasi Simulations: 1 (https://510kreport.com/company/dasi-simulations)

## Its most-cited devices
- K214066: FEops HEARTguide (2022), cited by 2
- DEN200030: FEops HEARTguide (2021), cited by 1

## Recent decisions
- K250635: FEops HEARTguide Simulation Application (Nov 25, 2025)
- K223855: FEops HEARTguideTM, FEops HEARTguideTM ALPACA (Jun 6, 2023)
- K214066: FEops HEARTguide (Feb 25, 2022)
- DEN200030: FEops HEARTguide (Sep 8, 2021)

Source page: https://510kreport.com/company/feops